Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark-Reference-Cited by-同舟云学术

Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark

Published:2021-09-16 Issue:10 Volume:20 Page:1327-1337
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Birck Anders Muusfeldt¹,Nordin Christensen Liv¹,Pedersen Mikkel H.²^ORCID,Olsen Jens²,Johnson Kelly D.³,Bencina Goran⁴^ORCID,Clausen Thomas Holtkøtter⁵,Larsen Carsten Schade⁶

Affiliation:

1. Infectious Diseases & Vaccines, Msd, Copenhagen, Denmark

2. Health Economics and Market Access, Incentive, Holte, Denmark

3. Outcomes Research, Merck & Co., Inc, Kenilworth, NJ, USA

4. Msd, Madrid, Spain

5. Lægerne Tronholmen, Randers, Denmark

6. Department of Clinical Medicine - Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Funder

MSD Denmark

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1977627

Reference35 articles.

1. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study

2. Sundhedsministeriet. Regering og folketing udvider vaccinationsprogram [Internet]. 2020 [cited 2021 Feb 3]. Available from: https://sum.dk/nyheder/2020/marts/regering-og-folketing-udvider-vaccinationsprogram-

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature;Human Vaccines & Immunotherapeutics;2023-11-28

2. A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult;Frontiers in Public Health;2023-06-29

3. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23;Journal of Medical Economics;2022-12-02